THE RELATIONSHIP BETWEEN THE INVITRO CHEMOSENSITIVITY OF TUMOR-CELLS AND TUMOR RESPONSE INVIVO IN AN EXPERIMENTAL TUMOR-MODEL

被引:6
作者
PHILLIPS, RM
BIBBY, MC
DOUBLE, JA
LOADMAN, PM
机构
[1] Clinical Oncology Unit, University of Bradford, Bradford, West Yorkshire
来源
INTERNATIONAL JOURNAL OF CELL CLONING | 1991年 / 9卷 / 02期
关键词
MURINE TUMORS; INVITRO CHEMOSENSITIVITY; INVIVO CHEMOSENSITIVITY; PHARMACOKINETICS; CHLORAMBUCIL;
D O I
10.1002/stem.5530090205
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Cell lines derived from a panel of five histologically distinct murine adenocarcinomas of the colon (MAC) were used to asses whether or not a colony-forming assay could have retrospectively predicted the wide range of in vivo responses to chlorambucil (CHL). The predictive value of the clonogenic assay was significantly improved when fractions (one-tenth) of the plasma drug AUC (from the area under the drug clearance curves;) were used to determine clonogenic cell kill in vitro, instead of one-tenth peak plasma drug concentration and total plasma drug AUC exposures. Despite the good correlation between in vitro and in vivo responses observed, the clonogenic assay could not forecast the site-dependent response of MAC 15A to CHL. These site-dependent responses cannot be explained in terms of the inherent sensitivity of tumor cells themselves, suggesting that caution must be applied in the interpretation of in vitro chemosensitivity assays.
引用
收藏
页码:144 / 154
页数:11
相关论文
共 24 条
[1]   STUDIES ON THE QUANTITATION OF CHLORAMBUCIL IN PLASMA BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
AHMED, AE ;
KOENIG, M ;
FARRISH, HH .
JOURNAL OF CHROMATOGRAPHY, 1982, 233 (DEC) :392-397
[2]  
ALBERTS DS, 1980, CLONING HUMAN TUMOR, P209
[3]  
ALIOSMAN F, 1987, CANCER RES, V47, P3718
[4]  
BIBBY MC, 1989, CANCER CHEMOTH PHARM, V24, P87
[5]  
BOSANQUET AG, 1986, CANCER CHEMOTH PHARM, V18, P176
[6]  
BOYD MR, 1989, INVEST NEW DRUGS, V7, pA349
[7]  
BRINDLEY CJ, 1987, CANCER CHEMOTH PHARM, V19, P221
[8]  
CORBETT TH, 1987, INVEST NEW DRUG, V5, P3
[9]  
DONELLI MG, 1977, CANCER TREAT REP, V61, P1319
[10]  
DOUBLE JA, 1975, CANCER CHEMOTH REP 1, V59, P1083